| Drug Name |
Esterified estrogens |
| Drug ID |
BADD_D00820 |
| Description |
Esterified estrogens contain a mixture of estrogenic substances; the principle component is estrone. Preparations contain 75% to 85% sodium estrone sulfate and 6% to 15% sodium equilin sulfate such that the total is not <90%. Esterified estrogens are a man-made mixture of estrogens that are used to treat symptoms of menopause such as hot flashes, vaginal dryness, vaginal burning or irritation, or other hormonal changes in the vagina. It is being also for the prevention and treatment of osteoporosis. |
| Indications and Usage |
Esterified estrogens are indicated to replace estrogen in women with ovarian failure or other conditions that cause a lack of natural estrogen in the body.
It is also indicated for the treatment of symptoms of breast cancer in both men and women. In men it can be used for the treatment of advanced prostate cancer.
It is also indicated for the treatment of menopausal symptoms. |
| Marketing Status |
approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB09381
|
| KEGG ID |
Not Available
|
| MeSH ID |
D042724
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
61570-074; 61570-075; 61570-073; 61570-072 |
| UNII |
Not Available
|
| Synonyms |
Estrogens, Esterified (USP) | Esterified Estrogens (USP) |
